Zydus receives final approval from USFDA for Roflumilast Tablets, 250 mcg
Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)
Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)
Several late-stage pipeline products have the potential to address some of these unmet needs
Estradiol Transdermal System USP, 0.014 mg/day (weekly) had annual sales of USD 1.9 mn in the United States
Isoproterenol hydrochloride injection is indicated to improve hemodynamic status in patients in distributive shock and shock due to reduced cardiac output
Affordability is key to providing accessible healthcare for Bharat.
The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova
Enabling wireless monitoring In ambulances and homes
Science communication brings behavioural changes
India's strategy against Covid was more effective than any other countries in the world
Subscribe To Our Newsletter & Stay Updated